• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number JF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pancreatitis (4481)
Event Date 01/17/2019
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled, "can iodixanol prevent post-endoscopic retrograde cholangiopancreatography pancreatitis? a prospective, randomized, controlled trial".Background: it is yet not clear whether differences in the contrast medium may affect post-endoscopic retrograde cholangiopancreatography (ercp) pancreatitis (pep).The aim of this study was to evaluate the rate of pep between high osmolality contrast medium (hocm) and iso osmolar medium (iocm) in a prospective, randomized, controlled trial.Methods: patients who were scheduled to undergo a diagnostic or therapeutic procedure under ercp guidance were included.Patients were excluded from this study if they (1) were <20 years old; (2) had acute or active pancreatitis; (3) had previously undergone ercp; (4) had surgical altered upper gastrointestinal tract anatomy; or (5) refused to be involved in this study.Results: seventy-five patients were randomly assigned to the iocm group, and 71 patients were assigned to the hocm group.Pep occurred in 27 patients (18.5%).Although there were no significant differences, the severe grade of pep was more frequent in the hocm group than in the iocm group (p = 0.08).The results of the multivariate analyses for pep were not identified as independent risk factors.Also, independent risk factors of hyperamylasemia were performing pre-cut.In subgroup analyses, hocm was an independent risk factor for hyperamylasemia.Conclusions: in conclusion, hocm may play a role in the development of pep and in pep severity grade.Type of adverse events/number of patients: post-ercp pancreatitis (mild) - 17 patients; post-ercp pancreatitis (moderate) - 8 patients; post-ercp pancreatitis (severe) - 2 patients; post-ercp hyperamylasemia - 56 patients.There is no report of any olympus device malfunction in any procedure described in this study.Since the literature described "visiglide 1", we selected "g-240-2545a" as a representative product.The product was unknown but a representative product was chosen for processing purposes.1.(b)(6) (for jf-260v).2.(b)(6) (for g-240-2545a).This report is submitted for (b)(6).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and to add additional information received from the author.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Event Description
The author confirmed the following: this event was not caused by an olympus device and there is no malfunction in olympus device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16721415
MDR Text Key313119523
Report Number9610595-2023-05969
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/12/2023
Initial Date FDA Received04/11/2023
Supplement Dates Manufacturer Received05/12/2023
Supplement Dates FDA Received05/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-